Clearside Biomedical (CLSD) PT Raised to $20 at Stifel

March 5, 2018 12:31 PM EST Send to a Friend
Stifel raised its price target on Clearside Biomedical (NASDAQ: CLSD) to $20.00 (from $15.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login